Multikinase inhibitors

Pfizer STN 50 mg Pill - brown capsule-shape, 18mm

Generic Name: sunitinib

Pill with imprint Pfizer STN 50 mg is Brown, Capsule-shape and has been identified as Sutent 50 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Sutent is used in the treatment of Gastrointestinal Stromal Tumor; Renal Cell Carcinoma; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Sutent (Sunitinib [ soo-nit-in-ib ])-Pfizer STN 50 mg-50 mg-Brown-Capsule-shape
Sutent (Sunitinib [ soo-nit-in-ib ])-Pfizer STN 50 mg-50 mg-Brown-Capsule-shape
Sutent (Sunitinib [ soo-nit-in-ib ])-Pfizer STN 50 mg-50 mg-Brown-Capsule-shape
Sutent (Sunitinib [ soo-nit-in-ib ])-Pfizer STN 50 mg-50 mg-Brown-Capsule-shape

Sutent
Generic Name: sunitinib [ soo-nit-in-ib ]
Imprint: Pfizer STN 50 mg
Strength: 50 mg
Color: Brown
Size: 18.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Multikinase inhibitors VEGF/VEGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00069-0980
Inactive Ingredients: Mannitol, Croscarmellose sodium, Povidone k25, Magnesium stearate, Titanium dioxide, Ferric oxide red, Ferric oxide yellow, Ferrosoferric oxide, Shellac, Propylene glycol, Sodium hydroxide, Potassium hydroxide,
Latest News
Related Drugs